drugset / Trial / NCT01631422
A Single Dose Study of Radiolabeled RO4602522 in Healthy Volunteers
Non-randomizedSingle-groupOpen-label
Summary
This single-center, open-label study will investigate the pharmacokinetics and elimination of a radiolabelled dose of RO4602522 in healthy male volunteers. The healthy male volunteers will receive a single oral dose of RO4602522.
Timeline
- Start
- 2012-06
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RO4602522 | Unknown | — | Oral |
Indications
No indication recorded.